Posluma

flotufolastat F 18

Approval

ApplicationNDA 216023
Approval dateMay 25, 2023
Approval year2023
SponsorBlue Earth

FDA-approved use

To use with positron emission tomography imaging in certain patients with prostate cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Posluma: